Hari, Tanggal

Thursday,June 22, 2017

Venue

PT Merck Sharp Dohme Pharma TBK
Wisma BNI 46, 27th floor
Jl. Jend. Sudirman Kav. 1
Jakarta

Time

10:00 WIB

Agenda

1. Approval of the company's annual report on the company's business activities and the financial administration for the financial year ended on December 31, 2016.

2. Ratification of the Company's balance sheet and income statement for the financial year ended on December 31, 2016 which has been audited by the public accounting firm, Tanudiredja, Wibisana & Rekan.

3. The Utilization of net profit for the financial year ended on December 31, 2016.

4. The appointment of a public accounting firm that will audit the financial statements of the company for the fiscal year ended on December 31, 2017, considering the proposal of the Board of Commissioners of the company, and determining the honorarium amount for the public accounting firm.

SCPI - PT. Organon Pharma Indonesia Tbk

Rp 29.000

0 (0%)